The generic name of Andadan is Dagliflozin. There is no such thing as “the dangers of long-term consumption of Andatang glucose-lowering drugs”, but the use of dagliflozin may have hypotension, ketoacidosis, renal impairment and acute kidney injury, pyelonephritis and other adverse reactions, it is recommended to follow the doctor’s instructions. Dagliflozin is a sodium-glucose co-transporter protein 2 inhibitor, which can inhibit sodium-glucose co-transporter protein 2, reduce the reabsorption of filtered glucose, lower the renal threshold of glucose, and thus increase urinary glucose excretion. It can be used for the treatment of type 2 diabetes mellitus in adults. It is contraindicated in patients with severe hypersensitivity reactions to this drug, severe renal impairment, end-stage renal disease or patients requiring dialysis. Hypotension, ketoacidosis, renal impairment and acute kidney injury, pyelonephritis, urinary sepsis may occur with the use of Dagliflozin, and adverse reactions such as hypoglycemia and fungal infections of the genitals may be caused by combining with insulinotropic agents and insulin. Patients who need to use Dagliflozin for treatment should use the drug under the guidance of a doctor, and it is recommended to go to the hospital if there are any uncomfortable symptoms after using the drug.